Top News

FDA Commissioner Scott Gottlieb, MD, Resigns

March 05, 2019

The FDA commissioner plans to leave the agency in April.

Roche to Acquire Spark Therapeutics

February 27, 2019

The $4.3-billion acquisition is expected to strengthen Roche’s gene therapy pipeline.

Danaher to Acquire GE’s Biopharma Business

February 25, 2019

The $21.4-billion acquisition will create stand-alone business within Danaher’s life-sciences portfolio.

Charles River to Acquire Citoxlab in $510-Million Deal

February 19, 2019

Pharmaceutical Technology's In the Lab eNewsletter

The acquisition would strengthen Charles River’s contract research capabilities.

SK Biopharmaceuticals, Arvelle Partner on Anti-Epileptic Drug for Europe

February 19, 2019

In a deal worth $530 million, the companies will develop and commercialize an anti-epileptic drug candidate in Europe.

FDA Big Winner in Final Congressional Budget Agreement

February 15, 2019

FDA came away with the largest boost in its annual budget in a decade as part of the final spending package approved by Congress this week.

GSK, Merck KGaA Partner in $4.2-Billion Cancer Immunotherapy Deal

February 08, 2019

The companies will jointly develop and commercialize an investigational bifunctional fusion protein immunotherapy currently in clinical development for cancer treatment.

FDA Seeks Participants in DSCSA Pilot Program

February 08, 2019

Supply chain players are eligible to participate in FDA’s pilot program to develop an electronic system for tracking drug products.

Janssen, MeiraGTx Partner on Eye-Focused Gene Therapy

February 01, 2019

Janssen and MeiraGTx will collaborate on the development and commercialization of gene therapies for treating inherited retinal diseases.

AstraZeneca Announces Organizational Changes

January 22, 2019

Company to focus on innovation, growth, and productivity with creation of new units.